March 10, 2014 Comments Off on Online and Onsite Biotechnology Bootcamps: Biotechnology Business, Law, Regulation, Policy and Science Posted in: General Biotechnology I have posted a series of free biotechnology training videos at BiotechU.com . The course is derived from my textbook, Building Biotechnology, and covers the following topics: Biotechnology Industry Introduction The Development of Biotechnology Preface: The Science of Biotechnology Introduction to Molecular Biology Drug Development Tools and Techniques Applications Preface: Laws, Regulations, and Politics Intellectual Property […]
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for March 4 2014
Instant Access to Deep Knowledge on Small-Molecule
DrugsSubscribers have
access to valuable datasets, including: - Patent litigation
- Clinical trial information
- International patent data
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Formulation
- Suppliers
- Dynamic search capabilities with data
export - More…
More than 6,400 small-molecule drugs from
1,700 branded and generic pharmaceutical companies and 700 suppliers, and
more than 80,000 U.S. and international patents.
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete detailsDISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for February 25 2014| Tradename | Applicant | Generic Name | Patent
Expiration |
|---|
ALVESCO | Takeda Gmbh | ciclesonide | Feb 25, 2014 | IMAGENT | Imcor Pharms Co | dimyristoyl lecithin; perflexane | Feb 25, 2014 | MYLOTARG | Wyeth Pharms Inc | gemtuzumab ozogamicin | Feb 25, 2014 | PROAIR HFA | Teva Branded Pharm | albuterol sulfate | Feb 25, 2014 | PROVENTIL-HFA | 3m | albuterol sulfate | Feb 25, 2014 | QNASL | Teva Branded Pharm | beclomethasone dipropionate | Feb 25, 2014 | QVAR
40 | Teva Branded Pharm | beclomethasone dipropionate | Feb 25, 2014 | QVAR
80 | Teva Branded Pharm | beclomethasone dipropionate | Feb 25, 2014 | XOPENEX HFA | Sunovion | levalbuterol tartrate | Feb 25, 2014 | ZETONNA | Takeda Gmbh | ciclesonide | Feb 25, 2014 | *Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details. |
Instant Access to Deep Knowledge on Small-Molecule
DrugsSubscribers have
access to valuable datasets, including: - Patent litigation
- Clinical trial information
- International patent data
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Formulation
- Suppliers
- Dynamic search capabilities with data
export - More…
More than 6,400 small-molecule drugs from
1,700 branded and generic pharmaceutical companies and 700 suppliers, and
more than 80,000 U.S. and international patents.
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete detailsDISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Like this:
Like Loading...
This spring has been a busy one for book launches — I have one final book to announce: The Success Matrix. The Success Matrix: Winning in Business and in Life takes a slightly different approach than most business books. A typical business book guides the reader through its prescribed methods and tools, using various real […]
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for February 22 2014
Instant Access to Deep Knowledge on Small-Molecule
DrugsSubscribers have
access to valuable datasets, including: - Patent litigation
- Clinical trial information
- International patent data
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Formulation
- Suppliers
- Dynamic search capabilities with data
export - More…
More than 6,400 small-molecule drugs from
1,700 branded and generic pharmaceutical companies and 700 suppliers, and
more than 80,000 U.S. and international patents.
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete detailsDISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Like this:
Like Loading...
March 3, 2014 Comments Off on A maturing industry: Strategic patenting trends, US and academic dominance, and the global biotechnology landscape Posted in: General Biotechnology This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
A maturing industry: Strategic patenting trends, US and academic dominance, and the global biotechnology landscape
Go to paperABSTRACT: Patent analytical da…
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for February 18 2014| Tradename | Applicant | Generic Name | Patent
Expiration |
|---|
GILENYA | Novartis | fingolimod | Feb 18, 2014 | *Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details. |
Instant Access to Deep Knowledge on Small-Molecule
DrugsSubscribers have
access to valuable datasets, including: - Patent litigation
- Clinical trial information
- International patent data
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Formulation
- Suppliers
- Dynamic search capabilities with data
export - More…
More than 6,400 small-molecule drugs from
1,700 branded and generic pharmaceutical companies and 700 suppliers, and
more than 80,000 U.S. and international patents.
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete detailsDISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Like this:
Like Loading...
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. Looking at the increasing therapeutic importance of peptide therapies, you may be surprised to learn that these (literal) building blocks of proteins have been defined away under the The […]
Like this:
Like Loading...
February 23, 2014 Comments Off on Drug Patent Expirations in February 2014 Posted in: General Biotechnology Drug Patent Expirations for February 2014
Tradename
Applicant
Generic Name
Patent Number
Patent Expiration
LEVEMIR INNOLET
Novo Nordisk Inc
insulin detemir recombinant
6,869,930
Feb 2, 2014
LEVEMIR PENFILL
Novo Nordisk Inc
insulin detemir recombinan…
Like this:
Like Loading...
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
This newsletter is
a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Drug Patent Expirations for February 15 2014| Tradename | Applicant | Generic Name | Patent
Expiration |
|---|
NIASPAN | Abbvie | niacin | Feb 15, 2014 | *Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details. |
Instant Access to Deep Knowledge on Small-Molecule
DrugsSubscribers have
access to valuable datasets, including: - Patent litigation
- Clinical trial information
- International patent data
- Paragraph IV challenges
- Tentative approvals
- Drug Master Files
- Formulation
- Suppliers
- Dynamic search capabilities with data
export - More…
More than 6,400 small-molecule drugs from
1,700 branded and generic pharmaceutical companies and 700 suppliers, and
more than 80,000 U.S. and international patents.
|
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete detailsDISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
Like this:
Like Loading...
